Company TheraVet SA

Equities

ALVET

BE0974387194

Biotechnology & Medical Research

Real-time Euronext Paris 04:31:20 2024-04-29 EDT 5-day change 1st Jan Change
0.7 EUR -1.41% Intraday chart for TheraVet SA -10.26% -51.72%

Business Summary

TheraVet SA is specialized in the development of pharmaceutical products for the treatment of osteoarticular diseases in pets.

At the end of 2023, the company had a portfolio of 2 products in the clinical development phase: Visco-Vet for the treatment of limping associated with osteoarthritis in dogs and Biocera-Vet for osseointegration and bone remodeling.

Number of employees: 8

Sales per Business

EUR in Million2021Weight2022Weight Delta
Osteoarticular Treatment
100.0 %
0 100.0 % 0 100.0 % +661.56%

Sales per region

EUR in Million2021Weight2022Weight Delta
United Kingdom
35.5 %
-- 0 35.5 % -
Belgium
26.4 %
0 62.1 % 0 26.4 % +223.31%
France
15.1 %
0 14.4 % 0 15.1 % +702.03%
Spain
9.4 %
-- 0 9.4 % -
United States
4.8 %
-- 0 4.8 % -
Netherlands
4.2 %
0 23.6 % 0 4.2 % +34.63%
Switzerland
1.2 %
-- 0 1.2 % -
Portugal
1.0 %
-- 0 1.0 % -
Ireland
0.8 %
-- 0 0.8 % -
Italy
0.7 %
-- 0 0.7 % -
Germany
0.6 %
-- 0 0.6 % -
Czech Republic
0.5 %
-- 0 0.5 % -

Managers

Managers TitleAgeSince
Founder - 17-11-20
Director of Finance/CFO - 23-10-23
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 14-06-30
Director/Board Member - 17-11-21
Corporate Officer/Principal - 20-08-31

Members of the board

Members of the board TitleAgeSince
Founder - 17-11-20
Chairman - 21-12-19
Director/Board Member - 21-12-19
Director/Board Member - 17-12-16
Director/Board Member - 17-11-21
Director/Board Member - -

Company contact information

TheraVet SA

Avenue Jean Mermoz 32/1

6041, Gosselies

+

http://www.thera.vet
address TheraVet SA(ALVET)